Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017; New Report Launched
Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 report provides an overview of the genetic disorders pipeline landscape, specifically focusing on muscular dystrophies. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Becker and Duchenne Muscular Dystrophy (BMD and DMD) and features dormant and discontinued projects. Both indications covered are inherited muscular dystrophies, a group of genetic, degenerative diseases primarily affecting voluntary muscles.
View full press release